World's First Novel 3-Dose Vaccine against Rabies

• 11 Apr 2022

• Pharmaceutical major Cadila Pharmaceuticals has developed the world's first novel three-dose vaccine against rabies.
• The three-dose vaccine, named as 'ThRabis', is a recombinant nano-particle based G protein vaccine which is prepared using Virus-like Particle technology.
• The three-dose schedule is spread over only one week.
• The new vaccine would prove to be a game-changer because all the existing rabies vaccines require five injections, spread over 28 days for eliminating the threat (of virus spread).